NCT02010827View on ClinicalTrials.gov

Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

August 31, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
BIOLOGICAL

isoglycemic intravenous glucose infusion and Glucagon infusion, day C

Infusion of 0.8ng/kg/min glucagon from time 0-25min

BIOLOGICAL

Oral glucose tolerance test, day A

BIOLOGICAL

intravenous iv glucose infusion, day B

Trial Locations (1)

2900

Diabetes Research Division, University Hospital Gentofte, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT02010827 - Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion | Biotech Hunter | Biotech Hunter